Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    0.00 (0.00%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £98.47m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

7 Jan 2016 07:00

RNS Number : 0828L
Somero Enterprises Inc.
07 January 2016
 

7 January 2016

Somero Enterprises, Inc.

("Somero" or the "Company")

 

Trading update

 

Somero is pleased to provide the following update on trading for the financial year ended 31 December 2015.

 

In the six months since 30 June 2015, the Company performed strongly, particularly in the final quarter with monthly sales at an all-time high in December, which is not traditionally the strongest month of the year. As a result, the Board is pleased to announce that the Company now expects to report Revenue ahead of current market expectations for the full year. Furthermore, as a result of an improved gross margin performance, the Company now expects to report EBITDA materially ahead of current market expectations for the period.

 

Demand in the second half of 2015 has remained robust across our core product range with North America and Europe contributing significantly to sales growth while performance in China was healthy and remained stable. The particularly strong finish to the year in Europe and full year performance in the Middle East notably exceeded the Board's prior expectations.

 

The year-end demand for the Company's products in North America was predominantly driven by technology upgrades and fleet additions, highlighting lengthy project backlogs for our customers that extend well into 2016.

 

On a product basis, while large line machine sales continue to represent the majority of our volume, small-line revenues, including the S-485 introduced at the end of 2014, were key contributors to growth.

 

While it is too early to provide detailed guidance for 2016, the Board is confident that it will deliver another year of growth and that the high-level of activity in December will continue into 2016 providing a solid start to the year.

 

Somero's final results for the year ending 31 December 2015 will be announced on 1 March 2016. 

 

 

For further information, please contact:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, CFO

Howard Hohmann, EVP Sales

 

Canaccord Genuity Ltd (NOMAD and Joint Broker)

Bruce Garrow +44 (0)20 7523 8000

Piers Coombs

Mark Whitmore

 

finnCap Ltd (Joint Broker)

Matt Goode +44 (0)20 7220 0500

Carl Holmes

Tim Redfern

 

Redleaf Communications Ltd (Financial PR Advisor) somero@redleafpr.com

Rebecca Sanders-Hewett +44 (0)20 7382 4730

David Ison

Susie Hudson

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKADBKBKBCDK
Date   Source Headline
6th May 20257:00 amRNSRestricted Stock Units, Director/PDMR Shareholding
1st May 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20257:00 amRNSAnnual Report and Notice of AGM
30th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20257:00 amRNSTrading Update
22nd Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20257:00 amRNSAppointment of New Chairman
11th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Apr 20254:35 pmRNSHolding(s) in Company
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Mar 20257:00 amRNSAppointment of New CEO
20th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSRSUs & Director/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20257:00 amRNSFinal Results
7th Mar 20252:35 pmRNSHolding(s) in Company
6th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Feb 20257:00 amRNSNotice of Investor Presentation
3rd Feb 20256:10 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNSTrading Update
20th Dec 20247:00 amRNSDirectorate Changes
17th Dec 20245:04 pmRNSHolding(s) in Company
5th Dec 20245:02 pmRNSHolding(s) in Company
5th Dec 20244:41 pmRNSHolding(s) in Company
4th Dec 20244:29 pmRNSHolding(s) in Company
26th Nov 20244:47 pmRNSHolding(s) in Company
21st Nov 20249:41 amRNSHolding(s) in Company
19th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Aug 20247:00 amRNSInterim Results
20th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20247:00 amRNSNotice of Investor Presentation
31st Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.